ARTICLE | Company News
Aastrom management update
December 17, 2012 8:00 AM UTC
Aastrom Biosciences Inc. (NASDAQ: ASTM), Ann Arbor, Mich. Business: Gene/Cell therapy Transitioning: Dan Orlando, chief commercial officer, to interim CEO, effective Dec. 14; he replaces Tim Mayleben,...